Synergistic Effects of the Combination of Alpelisib (PI3K Inhibitor) and Ribociclib (CDK4/6 Inhibitor) in Preclinical Colorectal Cancer Models.
Saved in:
| Title: | Synergistic Effects of the Combination of Alpelisib (PI3K Inhibitor) and Ribociclib (CDK4/6 Inhibitor) in Preclinical Colorectal Cancer Models. |
|---|---|
| Authors: | Aslam, Razia1,2,3 (AUTHOR) raslam33@gmail.com, Richards, Cathy E.1,2 (AUTHOR) catherinerichards@rcsi.ie, Fay, Joanna4,5 (AUTHOR), Hudson, Lance6 (AUTHOR) lhudson@rcsi.ie, Workman, Julie1 (AUTHOR), Lee, Cha Len1 (AUTHOR), Murphy, Adrian2,7 (AUTHOR), O'Neill, Brian8 (AUTHOR), Toomey, Sinead1,2 (AUTHOR) sineadtoomey@rcsi.ie, Hennessy, Bryan T.1,2,7 (AUTHOR) |
| Source: | International Journal of Molecular Sciences. Dec2024, Vol. 25 Issue 24, p13264. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
